comparemela.com

Sabine Brandt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innovative flu-based vaccine against equine sarcoids shows promise

The vaccine should render successfully treated horses immune to future infections by the bovine papillomaviruses that cause sarcoids.

Edmund hainischSabine brandtChristoph jindraUniversity of veterinary medicineBacillus calmette guKarl landsteiner universityHealth sciencesVeterinary medicineEquine sarcoidsFrom early approachesCreative commons license

Potential vaccines against papillomaviruses in horses show much promise - review

Papillomaviruses play a role in sarcoids and squamous cell carcinomas in horses.

Reinhard kirnbauerChristoph jindraEdmund hainischSabine brandtVeterinary universityMedical universityLike particlesCreative commons license

Potential role of herpesviruses in cancer in horses identified in study

In-depth studies are now required to determine whether herpesvirus types are causative agents, additional promotors, or innocent bystanders in tumor development.

Christoph jindraLea miglinciMichelle kochPaul reicherBarbara nellSabine brandtOncology research groupVeterinary universityDepartment for companion animalsClinical unitEquine surgeryCompanion animalsEquine papillomavirusesEquine squamous cellCreative commons license

Equine Sarcoids - visible success with delNS-based immunotherapy leads the way towards cancer therapy in humans

/PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids.

Thomas musterEdmund hainischBluesky immunotherapies gmbBluesky immunotherapiesSabine brandtIsoldem bergmannBluesky immunotherapies gmbh ltdUniversity of veterinary medicine viennaVeterinary medicine viennaMariahilfer straBluesky immunotherapies gmbhHealth care amp hospitalsStem scienceClinical trials amp medical discoveries

BlueSky Immunotherapies GmbH: Equine Sarcoids - visible success with delNS-based immunotherapy leads the way towards cancer therapy in humans

VIENNA, Dec. 10, 2021 /PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids in horses.

Kostenloser wertpapierhandelThomas musterEdmund hainischBluesky immunotherapies gmbBluesky immunotherapiesSabine brandtIsoldem bergmannBluesky immunotherapies gmbh ltdUniversity of veterinary medicine viennaVeterinary medicine viennaMariahilfer stra

vimarsana © 2020. All Rights Reserved.